Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction via Modulating PD-1 Methylation in Immune Thrombocytopenia

Panpan Han(Qilu Hospital of Shandong University), Ming Hou(Qilu Hospital of Shandong University)
Frontiers in Immunology
February 17, 2021
10.3389/fimmu.2021.630693
Cited by 39

Related Papers

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
GPIbα is required for platelet-mediated hepatic thrombopoietin generation
|Blood|2018|78
Sirolimus Combined Dexamethasone As the First-Line Therapy for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Open-Label, Prospective, Randomized Controlled Clinical Trial
|Blood|2024|1